Testing For Gilead’s Remdesivir To Treat COVID-19 Has Begun In Multiple Phase 3 Clinical Trials

AB Newswire is committed to help every business gain greater visibility via Press Release writing and distribution. On July 24, 2020, it released an article on the remdesivir market, sourced from TBRC`s Global Remdesivir Market report. The remdesivir market covered in this report is segmented by route of administration into oral, intravenous. It is also segmented by dosage form into tablets, frozen solution, lyophilized solution and by distribution channel into hospitals, clinics, drug stores/pharmacies, online, others.

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)